DATATRAK Hires Clinical Trial Industry Veteran, Dr. William (Bill) Gluck, to Head Clinical Services

DATATRAK Hires Clinical Trial Industry Veteran, Dr. William (Bill) Gluck, to Head Clinical Services
October 4th, 2010 - Filed under: Press Releases.

CLEVELAND, [October 4] /PRNewswire-FirstCall/ - DATATRAK International, Inc. (OTCQX: DATA), a technology and services company focused on global eClinical solutions for the clinical trials industry, today announced the appointment of William (Bill) Gluck, PhD, as the company's Vice President of Clinical and Consulting Services. Dr. Gluck, a thirty-year clinical trial industry veteran, will focus on building the company's consulting and clinical services business, which has received increased interest since the announcement of DATATRAK ONETM as a breakthrough approach to safety, simplicity and speed in eClinical solutions.

"With the growing concern of quality and safety in clinical studies, the financial burdens from the drop in approved drugs and the complexity of information silos due to integrated products, the addition of Bill to our team will strengthen our delivery of DATATRAK ONETM," said Laurence P. Birch, DATATRAK's Chairman of the Board. "Bill's expertise will allow us to expand our offerings resulting in increased customer satisfaction and market share."

Dr. Gluck has diversified experience in clinical trial management systems, electronic data capture and the services that surround these solutions. Prior to joining DATATRAK, he served in management roles in sponsor companies for over 18 years including Amgen, BASF Life Sciences, Gilead Sciences, and Triangle Pharmaceuticals. He also brings the perspective of the very important CRO organization having served in them for seven years. Finally, Dr. Gluck continues to apply his skills in academia in university settings.

"I believe that DATATRAK has the right vision to focus on improving the total clinical process for clients, not simply their technology choices," said Dr. Gluck. He stated further, "I am excited to join DATATRAK's quality team of professionals in executing their vision to become the clinical enterprise solution to safely accelerate every drug, every biologic and every device from concept to cure."

About DATATRAK International, Inc.
DATATRAK International is a worldwide technology and services company delivering eClinical solutions and related services for the clinical trials industry. DATATRAK built its multi-component, comprehensive solution on a single, unified platform and expanded this concept to include services delivery in DATATRAK ONETM, the seamless delivery of product and services. The Company delivers a complete portfolio of software products designed to accelerate the reporting of clinical research data from sites to sponsors and ultimately regulatory authorities, faster and more efficiently than loosely integrated technologies. The DATATRAK eClinicalTM software solution, deployed worldwide through an ASP or Enterprise Transfer offering, has successfully supported hundreds of international clinical trials involving thousands of clinical research sites and encompassing tens of thousands of patients in 59 countries. DATATRAK has offices located in Cleveland, Ohio, and Bryan, Texas. For more information, visit www.datatrak.net.

Except for the historical information contained in this press release, the statements made in this release are forward-looking statements. These forward-looking statements are made based on management's expectations, assumptions, estimates and current beliefs concerning the operations, future results and prospects of the Company and are subject to uncertainties and factors which are difficult to predict and, in many instances, are beyond the control of the Company, and which could cause actual results to differ materially from those contemplated in these forward-looking statements. For a list of certain of the factors that may cause actual results to differ materially from those contemplated in these forward looking statements, please see the Company's quarterly report filed with the Pink OTC Markets on August 13, 2010 announcing its results for the three-month period ending June 30, 2010. The Company undertakes no obligation to update publicly or revise any forward-looking statement whether as a result of new information, future events or otherwise.

CONTACT:
Lisa Pahl, Director Marketing, DATATRAK International, Inc., +1-979-393-9025

 

Suggested Articles

Eli Lilly is combining the oncology team at Lilly Research Laboratories with Loxo Oncology and putting a trio of Loxo execs at the helm.

The failure of SAGE-217 to beat placebo wiped more than 50% off Sage’s share price as investors digested the implications of the data.

The data tee Aurinia up to file for FDA approval next year and go on to address a major unmet medical need.